Search for: "IMPAX LABORATORIES INC"
Results 1 - 20
of 78
Sorted by Relevance
|
Sort by Date
14 Dec 2006, 6:47 am
Cir. 2006, 05-1313) Impax had originally filed an ANDA with the FDA seeking approval to market generic riluzole (6-trifluoromethoxy-2-benzothiazolamine) tablets for the treatment of ALS and prompting a suit for a declaratory judgment that Impax did not infringe, induce [...] [read post]
3 Dec 2008, 11:18 pm
By Sherri Oslick -- Earlier this week, Impax Laboratories, Inc. and Medicis Pharmaceutical Corp. announced that they have entered a Joint Development Agreement and a Settlement and License Agreement that brings to an end their pending lawsuit over Impax's plans to manufacture a generic version of Medics' Solodyn ® (minocycline hydrochloride extended release tablets, used to treat acne). [read post]
8 Oct 2008, 4:56 am
Seeking approval to market a generic version of riluzole, Plaintiff-Appellant Impax Laboratories, Inc. filed an Abbreviated... [read post]
23 May 2011, 9:59 pm
• Defendants: Impax Laboratories, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
12 Dec 2010, 9:47 pm
Hunt • Defendants: IMPAX Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc. [read post]
10 Jun 2010, 9:46 pm
By James DeGiulio -- Endo Settles with Impax and Sandoz in Opana Patent Suits Endo Pharmaceuticals Inc. has settled patent infringement suits against Sandoz Inc. and Impax Laboratories Inc. over generic versions of painkiller Opana ER. [read post]
3 Feb 2013, 8:26 pm
Laboratories, Inc.; Purdue Pharmaceuticals L.P.; Rhodes Technologies • Defendant: Impax Laboratories, Inc.... [read post]
20 Jun 2007, 1:07 am
The East Bay Business Times reported:Abbott Laboratories is suing Impax Laboratories Inc., alleging it infringed on a patent for the for the bipolar disorder and epilepsy medicine Depakote when filing an application to make a generic version of the drug. [read post]
2 Jun 2013, 8:40 pm
• Defendant: Impax Laboratories, Inc. [read post]
30 Apr 2018, 10:30 am
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
30 Apr 2018, 10:30 am
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
22 Mar 2009, 8:52 pm
Impax Laboratories, Inc. 2:09-cv-01233; filed March 18, 2009 in the District Court of New Jersey Infringement of U.S. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
11 Jan 2009, 8:25 pm
Impax Laboratories Inc.1:09-cv-00018; filed January 7, 2009 in the District Court of DelawareInfringement of U.S. [read post]
18 Nov 2008, 10:40 pm
Lilly also sued Sandoz Inc., Impax Laboratories Inc. and Cobalt Laboratories Inc. in separate lawsuits for seeking generic approval for Cymbalta tablets. [read post]
6 Apr 2009, 7:10 pm
Impax Laboratories, Inc. 1:09-cv-00846; filed April 3, 2009 in the District Court of Maryland Infringement of U.S. [read post]
18 May 2016, 9:56 pm
Impax Laboratories, Inc. 2:16-cv-02526; filed May 6, 2016 in the District Court of New Jersey Infringement of U.S. [read post]
24 Sep 2015, 8:43 am
On August 10th, the rights to sell Daraprim were bought from Impax Laboratories Inc. [read post]
5 Jul 2010, 9:47 pm
Impax Laboratories, Inc. 1:10-cv-01791; filed July 1, 2010 in the District Court of Maryland Genzyme Corp. v. [read post]
